Factor V Leiden and thromboembolism

被引：0
|
作者：
Walter, M [1 ]
Reinecke, H
Breithardt, G
Assmann, G
Heinrich, J
机构：
[1] Univ Hosp Munster, Dept Cardiol & Angiol, Inst Arteriosclerosis Res, Inst Clin Chem & Lab Med, Munster, Germany
[2] Community Hosp Solingen, Solingen, Germany
来源：
CIRCULATION | 1998年 / 97卷 / 14期
关键词：
D O I：
10.1161/01.CIR.97.14.1426
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1426 / 1426
页数：1
相关论文
共 50 条
  • [21] Factor V Leiden and the risk for venous thromboembolism in the adult Danish population
    Juul, K
    Tybjærg-Hansen, A
    Schnohr, P
    Nordestgaard, BG
    ANNALS OF INTERNAL MEDICINE, 2004, 140 (05) : 330 - 337
  • [22] The risk of recurrent venous thromboembolism in patients with and without factor V Leiden
    Eichinger, S
    Pabinger, I
    Stumpflen, A
    Hirschl, M
    Bialonczyk, C
    Schneider, B
    Mannhalter, C
    Minar, E
    Lechner, K
    Kyrle, PA
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (04) : 624 - 628
  • [23] Factor V Leiden and risks of recurrent idiopathic venous thromboembolism.
    Ridker, P
    Miletich, J
    Stampfer, M
    Goldhaber, S
    Hennekens, C
    BLOOD, 1995, 86 (10) : 2448 - 2448
  • [24] Activated protein C resistance, factor V Leiden, and venous thromboembolism
    Ridker, PM
    Price, DT
    PULMONARY EMBOLISM, 1999, : 37 - 53
  • [25] Factor V leiden: association with venous thromboembolism in pregnancy and screening issues
    Harvey, D
    Lowe, GM
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2004, 61 (03) : 157 - 164
  • [26] Apixaban Failure for Venous Thromboembolism Treatment with Heterozygous Factor V Leiden
    Albanese, S.
    Pilcher, M. B.
    Hutchison, L. C.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 : S257 - S258
  • [27] EVALUATION OF FACTOR V LEIDEN VARIANT AS RISK A FACTOR FOR VENOUS THROMBOEMBOLISM IN GLIOBLASTOMA PATIENTS
    Heenkenda, M.
    Lysiak, M.
    Akesson, L.
    Milos, P.
    Mudaisi, M.
    Bratthall, C.
    Strandeus, M.
    Soderkvist, P.
    Uppugunduri, S.
    Osman, A.
    Malmstrom, A.
    NEURO-ONCOLOGY, 2018, 20 : 267 - 267
  • [28] Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden
    Zaher K. Otrock
    Ali T. Taher
    Wael A. Shamseddeen
    Ghazi Zaatari
    Ali Bazarbachi
    Rami A. Mahfouz
    Annals of Hematology, 2008, 87 : 1013 - 1016
  • [29] The factor V Leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients
    Ravin, AJ
    Edwards, RP
    Krohn, MA
    Kelley, JR
    Christopherson, WA
    Roberts, JM
    OBSTETRICS AND GYNECOLOGY, 2002, 100 (06): : 1285 - 1289
  • [30] Lipoprotein(a), factor V Leiden mutation and the risk of future venous thromboembolism in women
    Danik, Jacqueline S.
    Glynn, Robert J.
    Buring, Julie E.
    Ricker, Paul M.
    CIRCULATION, 2007, 116 (16) : 819 - 819
12345